328 related articles for article (PubMed ID: 30390265)
1. Drugs of Muscle Wasting and Their Therapeutic Targets.
Sakuma K; Yamaguchi A
Adv Exp Med Biol; 2018; 1088():463-481. PubMed ID: 30390265
[TBL] [Abstract][Full Text] [Related]
2. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.
Anker MS; von Haehling S; Springer J; Banach M; Anker SD
Int J Cardiol; 2013 Jan; 162(2):73-6. PubMed ID: 23174169
[TBL] [Abstract][Full Text] [Related]
3. Acylated and unacylated ghrelin administration to blunt muscle wasting.
Reano S; Graziani A; Filigheddu N
Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):236-40. PubMed ID: 24572833
[TBL] [Abstract][Full Text] [Related]
4. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
5. Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.
Lena A; Anker MS; Springer J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911600
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia.
Sakuma K; Yamaguchi A
Pflugers Arch; 2018 Mar; 470(3):449-460. PubMed ID: 29043432
[TBL] [Abstract][Full Text] [Related]
7. Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders.
Smith RC; Lin BK
Curr Opin Support Palliat Care; 2013 Dec; 7(4):352-60. PubMed ID: 24157714
[TBL] [Abstract][Full Text] [Related]
8. The wasting continuum in heart failure: from sarcopenia to cachexia.
von Haehling S
Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
[TBL] [Abstract][Full Text] [Related]
10. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
Lan XQ; Deng CJ; Wang QQ; Zhao LM; Jiao BW; Xiang Y
Gen Comp Endocrinol; 2024 Jul; 353():114513. PubMed ID: 38604437
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
Hanada K; Fukasawa K; Hinata H; Imai S; Takayama K; Hirai H; Ohfusa R; Hayashi Y; Itoh F
Cancer Sci; 2022 Oct; 113(10):3547-3557. PubMed ID: 35849084
[TBL] [Abstract][Full Text] [Related]
12. Update on emerging drugs for sarcopenia - age-related muscle wasting.
Lynch GS
Expert Opin Emerg Drugs; 2008 Dec; 13(4):655-73. PubMed ID: 19046133
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action.
Dutt V; Gupta S; Dabur R; Injeti E; Mittal A
Pharmacol Res; 2015 Sep; 99():86-100. PubMed ID: 26048279
[TBL] [Abstract][Full Text] [Related]
14. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
Koopman R; Ryall JG; Church JE; Lynch GS
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic options for cachexia and sarcopenia.
Molfino A; Amabile MI; Rossi Fanelli F; Muscaritoli M
Expert Opin Biol Ther; 2016 Oct; 16(10):1239-44. PubMed ID: 27382931
[TBL] [Abstract][Full Text] [Related]
16. Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida K
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
[TBL] [Abstract][Full Text] [Related]
17. The role of vitamin D in cancer cachexia.
Penna F; Camperi A; Muscaritoli M; Filigheddu N; Costelli P
Curr Opin Support Palliat Care; 2017 Dec; 11(4):287-292. PubMed ID: 28922293
[TBL] [Abstract][Full Text] [Related]
18. Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice.
Bonetto A; Penna F; Minero VG; Reffo P; Bonelli G; Baccino FM; Costelli P
Curr Cancer Drug Targets; 2009 Aug; 9(5):608-16. PubMed ID: 19508174
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin: from discovery to cancer cachexia therapy.
Molfino A; Formiconi A; Rossi Fanelli F; Muscaritoli M
Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):471-6. PubMed ID: 24905862
[TBL] [Abstract][Full Text] [Related]
20. Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse Model.
Hong M; Han IH; Choi I; Cha N; Kim W; Kim SK; Bae H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
